Need help? Contact us at (800) 824-8540.

Products: Primary Antibodies

Anti-SALM5/LRFN5 (N140A/12)


 Download Full Datasheet

PRODUCT OPTIONS

Catalog # Option Volume Concentration Price*
Catalog #
75-192
Option
Purified
Volume
100 µL
Concentration
1 mg/mL
Price
$269.00
Catalog #
73-192
Option
TC Supernatant
Volume
5 mL
Concentration
Lot dependent
Price
$269.00

Overview

Brand:

NeuroMab

Antibody Type:

Monoclonal

Host Species:

Mouse

Antibody Isotype:

IgG1

Species Reactivity:

Mouse

Applications:
WB Western Blot
IHC Immunohistochemistry
ICC Immunocytochemistry
IP Immunoprecipitation
AT Array Tomography
EM Electron Microscopy
CHIP Chromatin Immunoprecipitation
DB Dot Blot

ICC IHC WB

Immunogen:

Fusion protein amino acids 551-719 (cytoplasmic C-terminus) of mouse SALM5 (also known as Leucine-rich repeat and fibronectin type-III domain-containing protein 5, Lrfn5 and C14orf146, accession number Q8BXA0)
Human: 90% identity (153/169 amino acids identical)
50% identity with SALM1

Cross Reactivity:

Does not cross-react with SALM1

Protein Name(s):

Leucine-rich repeat and fibronectin type-III domain-containing protein 5

Gene Name(s):

Lrfn5 Kiaa4208 Salm5

Antibody Registry ID:

Purified: AB_10698028
TC Supernatant: AB_10672419


Antibody Validation and Application Notes


This antibody has been validated using the following assays:
Western Blot:

This antibody recognizes a single immunoreactive band of expected molecular weight when used to probe lysate from COS cells overexpressing target.

Immunocytochemistry:

This antibody shows the expected staining pattern when used to stain COS cells overexpressing target.

Immunohistochemistry:
This antibody shows the expected immunoperoxidase-diaminobenzidine/immunofluorescence staining pattern when used to stain brain sections.

Expected Banding Pattern:

~110 kDa(larger than calculated 80 kDa due to post-translational modification)


Quality Control


The following quality control assay is performed on each new lot of this antibody to ensure it meets designated performance requirements.

Each new lot of this antibody is tested to confirm that it shows the expected immunoperoxidase-diaminobenzidine/immunofluorescence staining pattern when used to stain brain sections.